Table 2.
Perioperative outcomes
| Characteristic | Patients (n = 70) |
|---|---|
| Surgical type, n (%) | |
| Laparoscopic | 9 (12.9) |
| Open | 61 (87.1) |
| Major hepatectomy, n (%) | 51 (72.9) |
| Operative time, min (range) | 205 (90–340) |
| Blood loss, mL (range) | 300 (100–6,000) |
| Blood loss, n (%) | |
| <500 mL | 43 (61.4) |
| ≥500 mL | 27 (38.6) |
| Blood transfusion, n (%) | |
| Yes | 24 (34.3) |
| No | 46 (65.7) |
| Pathological reaction, n (%) | |
| PCR | 29 (41.4) |
| MPR | 59 (84.3) |
| Microvascular invasion, n (%) | |
| M0 | 50 (71.4) |
| M1 | 13 (18.6) |
| M2 | 7 (10) |
| Clavien-Dindo classification, n (%) | |
| 0–IIIa | 65 (92.9) |
| IIIb-V | 5 (7.1) |
| Post-hepatectomy liver failure, n (%) | 16 (22.9) |
| Post-hepatectomy liver failure, n (0/A/B/C) | 54/12/2/2 |
| Postoperative hospital stay, days (range) | 10 (5–28) |
PCR, pathological complete response; MPR, major pathological response.